GondolaBio is a clinical-stage biopharmaceutical company focused on developing breakthrough therapeutics for genetic diseases. GondolaBio is an independent sister company to BridgeBio, originally carved out in 2024 after securing $300M in private financing from external investors. GondolaBio aims to leverage cutting-edge biological research to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases. We’re seeking an entrepreneurial scientific leader with deep expertise in in vitro and ex vivo electrophysiology to advance GondolaBio’s rare disease pipeline. You will serve as the scientific lead for multiple preclinical programs where electrophysiology plays a critical role in understanding target biology and driving drug discovery. You will design, execute, and interpret electrophysiology experiments that guide compound optimization and translational strategy. This role offers the opportunity to shape research strategy, build electrophysiology capabilities, and mentor junior scientists while contributing to a growing interdisciplinary team. You will thrive in an environment where scientific rigor, creativity, and collaboration are valued equally, and where your work directly informs the development of transformative medicines for patients.